Forum Selection Clause, on Its Own, Does Not Bar PTAB from Instituting IPR Petition

Oct 18, 2019

Reading Time : 4 min

Petitioner filed an IPR challenging claims of a patent directed to the design, operation and method of manufacture of an efficient inductor and related systems. Patent Owner and Petitioner signed an NDA containing a forum selection clause that specified that “[a]ny legal action, suit or proceeding arising out of or relating to this Agreement or the transactions contemplated hereby must be instituted exclusively . . . within the Borough of Manhattan, City of New York, State of New York and in no other jurisdiction.” After their business relationship deteriorated, Patent Owner filed suit against Petitioner in the Eastern District of Texas (EDTX). Petitioner successfully filed a motion to transfer the case to the Southern District of New York (SDNY) on the grounds that Patent Owner’s causes of action fell within the scope of the NDA’s forum selection clause. After Petitioner filed the IPR, Patent Owner filed a motion for preliminary injunction requesting that the district court order Petitioner to withdraw its petition. The court denied the motion and stayed the infringement litigation pending resolution of the IPR proceeding.

Before the Board, Patent Owner made four arguments for why the Board should not institute the IPR. First, Patent Owner stated that the parties had litigated the forum selection clause issue in EDTX, resulting in a transfer to SDNY and, therefore, issue preclusion foreclosed Petitioner from bringing an invalidity challenge in any other forum. On this issue, the Board disagreed that issue preclusion was applicable because the Board had consistently held that equitable estoppel defenses, including contractual estoppel based on a forum selection clause, are not a proper basis to deny institution. The Board noted that while Congress expressly allowed for estoppel in limited circumstances, such as estoppel based on a party’s previous challenge to the same patent, Congress had not allowed contractual estoppel as a defense to unpatentability. Furthermore, even if equitable estoppel defenses were proper in IPR proceedings, Patent Owner had already argued issue preclusion in SDNY and lost. According to that court, Patent Owner had failed to show that the claims at issue were subject to the forum clause; furthermore, the NDA had expired more than a year before Petitioner filed its petition; and the petition did not relate to the surviving confidentiality obligations. Additionally, the Board noted that SDNY found that Petitioner did not brief, and EDTX did not decide, whether the NDA’s forum selection clause could apply to an IPR proceeding unrelated to a disclosure of confidential information and filed after the expiration of the NDA. Therefore, the Board rejected the issue preclusion argument.

Second, Patent Owner asserted that the Federal Circuit’s decision in Dodocase VR, Inc. v. MerchSource, LLC, No. 2018-1724, 2019 WL 1758481 (Fed. Cir. Apr. 18, 2019) controlled the outcome of Petitioner’s IPR challenge. In that case, Dodocase sought an injunction against MerchSource to prevent the cessation of royalty payments under a Master License Agreement with a forum selection clause. Dodocase, 2019 WL 175848 at *1. MerchSource then filed petitions before the Board, and Dodocase filed a motion for preliminary injunction requesting withdrawal of those petitions. Id. The district court granted the preliminary injunction and, on appeal, the Federal Circuit agreed that the parties could not pursue validity challenges before the Board and ordered MerchSource to withdraw its petitions. Id. at *2. Patent Owner argued that here, like in Dodocase, the forum selection clause would control, and thus the Board should deny institution. The Board distinguished Dodocase by referring to the analysis from SDNY, which had determined that the claims at issue were not subject to the forum selection clause. The Board further noted that, even if they were subject to the forum selection clause, the Dodocase was still distinguishable because in that case the license agreement included a clause in which the licensee agreed not to challenge the patents. When considered together with Dodocase’s status as a non-precedential opinion, the Board concluded that the Federal Circuit’s decision had little relevance to the present matter.

Third, Patent Owner argued that because Petitioner made statements regarding the scope of the forum selection clause when seeking to transfer the case to SDNY, it was judicially estopped from controverting these statements before the Board, and had therefore waived its right to request the Board to exercise its jurisdiction. The Board reiterated that judicial estoppel, like contractual estoppel, is not a defense to an IPR and determined that SDNY’s findings were sufficient to conclude that the forum selection clause did not apply to this case.

Finally, Patent Owner asserted that Petitioner had made allegedly inconsistent statements before the district courts and the Board, and in light of those statements, the Board should have denied institution. In particular, Patent Owner argued that Petitioner did not inform the Board of the history between the parties, the forum selection clause, or that Petitioner had sought enforcement of the clause in another forum, thus acting inconsistently with its previous filing in EDTX. Furthermore, Patent Owner alleged that Petitioner had argued before SDNY that the purpose of an IPR is to define the scope of the prior art, rather than what Patent Owner believed to be the actual purpose, that is, cancelling one or more patent claims. The Board stated that EDTX had not decided whether Petitioner is barred from requesting an IPR, and SDNY had indicated by denying the preliminary injunction (and issuing a stay) that Petitioner was not precluded from pursuing the IPR petition. Therefore, the Board was unconvinced that Petitioner’s statements required it to exercise its discretion to deny the IPR.

Practice Tip: Patent owners should be aware that a forum selection clause on its own may not prevent a petitioner from bringing an IPR before the Board. Instead, patent owners wishing to avoid Board review should consider pairing the forum selection clause with a clause in which the would-be petitioner agrees not to challenge the patents.

Case: Samsung Elecs. Co., Ltd. v. NuCurrent, Inc., IPR2019-00863, Paper 14 (PTAB Oct. 7, 2019)

Share This Insight

Previous Entries

IP Newsflash

November 14, 2025

The Ninth Circuit recently reversed a district court’s decision to strike a plaintiff’s trade secret claims under the Defend Trade Secrets Act (DTSA) at the discovery stage. In doing so, the Ninth Circuit made clear that under the DTSA, whether a party defined their trade secret with sufficient particularity is a question of fact that generally does not lend itself to resolution in the absence of at least some discovery. This ruling contrasts with the California Uniform Trade Secrets Act (CUTSA), which requires a party to define their trade secrets with reasonable particularity before commencing discovery.

...

Read More

IP Newsflash

November 11, 2025

The Federal Circuit recently vacated a summary judgment ruling of invalidity, holding that the district court erred in applying preclusive effect to the Patent Trial and Appeal Board’s unpatentability findings regarding other claims in the same patent. In doing so, the Federal Circuit reiterated that issue preclusion does not apply where the prior factual determinations were made under a lower standard of proof.

...

Read More

IP Newsflash

November 3, 2025

The Federal Circuit recently clarified the requirement for work disclosed in a reference to qualify as “by another” under pre-AIA Sections 102(a) and (e), holding that there must be complete inventive identity between the information disclosed in the asserted reference and the inventors named on the relevant patent. 

...

Read More

IP Newsflash

October 31, 2025

The District Court for the Northern District of California recently granted a defendant’s motion to bifurcate, ordering that issues related to PGR estoppel should be decided in a bench trial, while the remaining issues in the case should proceed to a jury trial.

...

Read More

IP Newsflash

October 31, 2025

The Northern District of Iowa recently held that a defendant’s motion for partial summary judgment of invalidity was barred after the PTAB issued final written decisions, regardless of when the motion was filed. The defendant filed its motion before the final written decisions were issued, but the court rejected the defendant’s argument that the timing of the motion insulated it from estoppel.

...

Read More

IP Newsflash

October 1, 2025

In a recent final written decision, the PTAB determined that a reference patent was not prior art, despite the petitioner’s post‑filing attempt to correct its petition. While the petitioner argued that it intended to rely on the patent application’s earlier date of publication, both the corrected petition and the expert declaration continued to reference the issued patent rather than the published application.

...

Read More

IP Newsflash

September 30, 2025

The USPTO Director recently granted a petitioner’s request for rehearing of the decision discretionarily denying institution of inter partes review, ultimately vacating the original decision, and referring the petition to the board for an institution decision.

...

Read More

IP Newsflash

September 25, 2025

In considering claims to a method of reducing cardiovascular events, the Federal Circuit held that the term a “clinically proven effective” amount did not render the claims patentable over the prior art. Specifically, the Federal Circuit held that the “clinically proven effective” amount, whether limiting or not, could not be used to distinguish the prior art because the claims also specified the exact amount of the drugs to be administered in the method. The Federal Circuit also rejected patentee’s evidence of unexpected results because that evidence was tied solely to the “clinically proven effective” limitation.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.